CEO wants to make Bavarian Nordic one of the world's largest vaccine companies
Paul Chaplin wants to achieve the goal, which will require annual sales of over USD 1bn, in 2025 at the latest.
by freja celine eriksen, translated by catherine brett
Becoming one of the world's largest companies that focuses exclusively on vaccines in 2025 at the latest will require the current yearly revenue to triple, says Paul Chaplin, CEO of Bavarian Nordic, to Danish financial daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
